By a five-to-four vote, the Supreme Court just ruled against preemption in the "light cigarette" case of Altria v. Good.
Here's a link to the opinion at the Supreme Court website.
Subscribe to:
Post Comments (Atom)
About
Blogging Team
Bexis' Book
Links
- Abnormal Use
- American Law Institute
- Cal Biz Lit
- Class Action Countermeasures
- Drugwonks
- Eye on FDA
- FCA Alert
- FDA
- FDA Intelligence
- FDA Law Blog
- FDA Lawyers Blog
- Federal Judicial Center
- Global Class Actions Clearinghouse
- Jackson on Consumer Class Action & Mass Torts
- Judicial Panel on Multidistrict Litigation
- Lawsuit Reform Watch
- Life Sciences Legal Update
- Mass Tort Defense
- Medical Devices Today
- National Center for State Courts
- National Library of Medicine/NIH
- New Jersey Mass Tort Information Center
- Nuisance Law
- Online Drug Encyclopedia
- Pharma Business Review
- Pharma Exec Blog
- Pharmalot
- Point of Law
- Product Liability Monitor
- Tort Talk
- Torts Prof
- Virginia Product Liability Blog
- Wall Street Journal Health Blog
- Wall Street Journal Law Blog
- WLF Legal Pulse
Links
Subscribe To
Posts
Comments
Topics
- Abigail Alliance (4)
- Accounting Standards (6)
- Accutane (14)
- Actos (1)
- Adverse Event Reporting (14)
- alabama (9)
- Alaska (1)
- ALI (11)
- Alternative Dispute Resolution (2)
- Amicus Curiae (13)
- Antitrust (3)
- Aredia/Zometa (29)
- Arkansas (5)
- Attorney-Client Privilege (13)
- Bankruptcy (2)
- Bartlett (18)
- Biomaterials (3)
- Bisphosphonates (1)
- Black Box Warning (4)
- Blogging (60)
- Bruesewitz (10)
- Bulk Supplier (2)
- Bystander (1)
- CAFA (18)
- California (40)
- Canada (7)
- Causation (74)
- CBE Regulation (12)
- Celebrex (2)
- Cheat Sheet (9)
- Choice Of Law (38)
- Class Action (147)
- Clinical Trials (14)
- Colacicco (31)
- Collateral Estoppel (12)
- Colorado (3)
- Comity (1)
- Comment K (15)
- Comparative Warnings (2)
- Compensable Injury (12)
- Compliance Defense (7)
- Component Parts (2)
- Confidentiality (17)
- Connecticut (3)
- Consolidation (5)
- Constitutional Law (12)
- Consumer Fraud (76)
- Conte (37)
- Contract (1)
- Copromotion (1)
- Criminal law (2)
- Cross-Examination (1)
- Cy Pres (2)
- Damages (5)
- Daubert (63)
- Dear Doctor Letters (1)
- Debarment (1)
- Delaware (6)
- Design Defect (35)
- Direct To Consumer Advertising (5)
- Discovery (46)
- Discovery Rule (4)
- Distributors (1)
- Document Production (3)
- Due Process (2)
- Duty To Test (13)
- Duty To Train (1)
- E-Discovery (21)
- Economic Loss (6)
- Emotional Distress (1)
- Epidemiology (9)
- Erie (1)
- Erie Doctrine (14)
- Evidence (33)
- Expert Witness Opinion On Law (11)
- Expert Witnesses (82)
- Express Preemption (103)
- Express Warranty (10)
- Extraterritoriality (4)
- False Claims Act (18)
- FDA (80)
- FDA Deference (26)
- FDA Evidence (23)
- FDA On Preemption (22)
- Fen-Phen (3)
- Field Preemption (3)
- First Amendment (43)
- Florida (15)
- Food (25)
- Foreign Regulations (7)
- Foreseeability (3)
- Forum Non Conveniens (14)
- Fosamax (12)
- Fraud (16)
- Fraud On The FDA (36)
- Fraudulent Joinder (16)
- Fraudulent Misjoinder (3)
- Gadolinium (1)
- Generic Drugs (91)
- Genetics (2)
- Georgia (4)
- Good Samaritan liability (1)
- Government Contingent Fee Contracts (8)
- Government Cost Recovery (2)
- Gunvalson (7)
- Hawaii (1)
- Heeding Presumption (13)
- HIPAA (5)
- Hospital Liability (3)
- HRT (12)
- Illinois (15)
- Implied Preemption (110)
- Implied Warranty (9)
- In-House Counsel (2)
- Indiana (6)
- Informed Consent (12)
- international (16)
- Interviewing Treating Physicians (14)
- Investigational Device (6)
- Investigational Drug (8)
- Iowa (3)
- Iqbal (31)
- Judicial Estoppel (2)
- Judicial Notice (5)
- Jurisprudence (49)
- Kent (16)
- Kentucky (6)
- Labor Law (2)
- Law Review Articles (56)
- Learned Intermediary (101)
- Legal Writing (4)
- Legislation (36)
- Levine (62)
- Lists (17)
- Lone Pine Order (5)
- Lost Chance/Increased Risk (1)
- Louisiana (7)
- Malpractice (1)
- Manufacturer's Representatives (8)
- Manufacturing Defect (8)
- Market Share Liability (2)
- Marketing (5)
- Maryland (2)
- Mass Torts (41)
- Massachusetts (3)
- MDL (94)
- Medical Device (116)
- Medical Monitoring (23)
- Medicare (7)
- Michigan (2)
- Minnesota (14)
- Mirapex (1)
- Misjoinder (4)
- Mississippi (7)
- Missouri (8)
- Misuse (3)
- Montana (4)
- Motion In Limine (5)
- Necessary Parties (1)
- Negligence Per Se (25)
- Neurontin (5)
- Nevada (4)
- New Hampshire (3)
- New Jersey (50)
- New Mexico (3)
- New York (16)
- North Carolina (3)
- Nuisance (10)
- Nuvaring (9)
- Off-Label Use (78)
- Ohio (12)
- Oklahoma (7)
- Oregon (3)
- Over The Counter Drugs (3)
- Overpromotion (1)
- Pain Pump (32)
- Parallel Violation Claims (46)
- Pennsylvania (71)
- Personal Jurisdiction (7)
- Pharmacy Liability (9)
- plea (1)
- Pleading (111)
- Practice Of Law (16)
- Preemption (257)
- Presumption Against Preemption (14)
- Principles Of Aggregate Litigation (9)
- Private Right Of Action (31)
- Product Identification (17)
- Publisher liability (3)
- Puerto Rico (1)
- Punitive Damages (46)
- Recall (9)
- Reliance (6)
- Removal (64)
- replevin (1)
- Reprocessing (1)
- Res Ipsa Loquitur (8)
- Resources (1)
- Restatement Third (7)
- Rhode Island (4)
- RICO (12)
- Riegel (34)
- Risperdal (1)
- Safe Harbor (7)
- Sanctions (6)
- Science (10)
- Scorecards (8)
- Securities Law (4)
- Seroquel (13)
- Settlement (15)
- Severance (1)
- South Carolina (2)
- South Dakota (2)
- SSRIs (28)
- standing (15)
- State Of The Art (11)
- Statute Of Limitations (25)
- Statute Of Repose (3)
- Strict Liability (8)
- Subject Matter Jurisdiction (3)
- Subsequent Remedial Measures (9)
- Supreme Court (57)
- Taxation (4)
- Tennessee (7)
- Texas (28)
- Third-Party Payer (23)
- Tolling (14)
- Tort Reform (10)
- Translation Costs (1)
- Unavoidably Unsafe Product (3)
- Unjust Enrichment (8)
- Utah (1)
- Vaccine Act (17)
- Vaccines (12)
- Viagra (1)
- Vioxx (30)
- Virginia (4)
- Voir Dire (3)
- Vytorin (3)
- Warning Adequacy (27)
- Warnings (52)
- Warranty (9)
- West Virginia (15)
- Wisconsin (6)
- Wyoming (1)
- Zyprexa (31)
Followers
|
| Subscribe to Drug and Device Law (by email) |
| Visit this group |
1 comment:
Gotta love the return to the presumption against preemption. Worried about the qualifier "ordinarily."
Post a Comment